Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy
This study has been completed.
Study NCT00927914   Information provided by Eisai Inc.

First Received on June 24, 2009.   Last Updated on March 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Polyneuropathies
More general conditions related to this trial
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Interventions listed in this trial
Ranirestat
Placebo
Sponsors listed in this trial
Eisai Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services